Back to News
Market Impact: 0.12
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
Source: newsfilecorp.com
Healthcare & Biotech
WELLTRUST, a consented patient database for clinical-trial and research-study recruitment, surpassed 100,000 patient consents after launching in February 2026. The milestone expands the pool of patients who have agreed to be contacted for health-circumstance-matched research opportunities, though no financial impact or commercial metrics were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- J&J prostate cancer drug shows promising tumor responses in early trial
- Oncologists Cheer Melanoma Data
- Investing.com’s stocks of the week
- Jefferies raises Zymeworks stock price target on Roche deal